Silence Therapeutics plc business relationships
Companies named in Silence Therapeutics plc’s 10-K filed 2026-03-05, and public companies whose annual reports name Silence Therapeutics plc. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.7 / 10
- AI naming
- 22 / 100 Top 1% in its category
- Agent readiness
- 0 / 100
- AI adoption
- 0 / 100
Named in Silence Therapeutics plc’s annual report 3
“Research Collaboration, Option and License Agreement, by and between the registrant and AstraZeneca AB, dated March 24, 2020” SEC filing
“Research collaboration - AstraZeneca” SEC filing
- Hansoh Pharmaceutical Group (HNPHY)Partner-
“...past, we have entered into collaborations with other parties, including pharmaceutical and biotechnology companies like Hansoh Pharmaceutical Group Company Limited, or Hansoh, and AstraZeneca PLC, or AstraZeneca, to develop products based on our RNAi technology, and such collaborations and licensing...” SEC filing
Companies whose annual reports name Silence Therapeutics plc 1
“...rapeutics, Inc., Eli Lilly and Company, GlaxoSmithKline plc, Novartis, Novo Nordisk A/S, or Novo Nordisk, SanegeneBio, Sarepta Therapeutics, Inc., Silence Therapeutics plc, Takeda Pharmaceutical Company Ltd., and Wave Life Sciences Ltd., as well as our collaborators Regeneron, Roche, Sanofi and Vir.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.